Biomarkers for Personalized Neoadjuvant Therapy in Triple-Negative Breast Cancer: Moving Forward

被引：0
|
作者：
Rauch, Gaiane M. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Unit 1473, 1515 Holcombe Blvd, Houston, TX 77030 USA
来源：
RADIOLOGY | 2024年 / 312卷 / 03期
关键词：
D O I：
10.1148/radiol.242011
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer
    Braydon Meyer
    Samuel Clifton
    Warwick Locke
    Phuc-Loi Luu
    Qian Du
    Dilys Lam
    Nicola J. Armstrong
    Beena Kumar
    Niantao Deng
    Kate Harvey
    Alex Swarbrick
    Vinod Ganju
    Susan J. Clark
    Ruth Pidsley
    Clare Stirzaker
    Clinical Epigenetics, 2021, 13
  • [42] Novel Biomarkers to Guide Immunotherapy De-Escalation in the Neoadjuvant Setting in Triple-Negative Breast Cancer
    Gandhi, Shipra
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (09):
  • [43] Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer
    Meyer, Braydon
    Clifton, Samuel
    Locke, Warwick
    Luu, Phuc-Loi
    Du, Qian
    Lam, Dilys
    Armstrong, Nicola J.
    Kumar, Beena
    Deng, Niantao
    Harvey, Kate
    Swarbrick, Alex
    Ganju, Vinod
    Clark, Susan J.
    Pidsley, Ruth
    Stirzaker, Clare
    CLINICAL EPIGENETICS, 2021, 13 (01)
  • [44] New Biomarkers and Treatment Advances in Triple-Negative Breast Cancer
    El Hejjioui, Brahim
    Lamrabet, Salma
    Joutei, Sarah Amrani
    Senhaji, Nadia
    Bouhafa, Touria
    Malhouf, Moulay Abdelilah
    Bennis, Sanae
    Bouguenouch, Laila
    DIAGNOSTICS, 2023, 13 (11)
  • [45] Immune-related biomarkers in triple-negative breast cancer
    Juan Zhang
    Qi Tian
    Mi Zhang
    Hui Wang
    Lei Wu
    Jin Yang
    Breast Cancer, 2021, 28 : 792 - 805
  • [46] Breast-Conserving Therapy for Triple-Negative Breast Cancer
    Gangi, Alexandra
    Chung, Alice
    Mirocha, James
    Liou, Douglas Z.
    Leong, Trista
    Giuliano, Armando E.
    JAMA SURGERY, 2014, 149 (03) : 252 - 258
  • [47] Extent of Breast Surgery After Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
    Benson, John R.
    Dumitru, Dorin
    JAMA SURGERY, 2020, 155 (08) : 784 - 785
  • [48] Impact of serial biopsies in triple-negative breast cancer patients receiving neoadjuvant systemic therapy
    Yam, C.
    Raghavendra, A.
    Hess, K. R.
    Adrada, B. E.
    Candelaria, R. P.
    Damodaran, S.
    Gilcrease, M. Z.
    Helgason, T.
    Hortobagyi, G. N.
    Huo, L.
    Layman, R. M.
    Lim, B.
    Litton, J. K.
    Mittendorf, E. A.
    Murthy, R. K.
    Piwnica-Worms, H.
    Rauch, G. M.
    Santiago, L.
    Symmans, F.
    Thompson, A. M.
    Tripathy, D.
    Ueno, N. T.
    Valero, V.
    Barcenas, C. H.
    Moulder, S. L.
    Yang, W.
    CANCER RESEARCH, 2019, 79 (04)
  • [49] Neoadjuvant therapy in triple-negative breast cancer: A systematic review and network meta-analysis
    Lin, Ying-Yi
    Gao, Hong-Fei
    Yang, Xin
    Zhu, Teng
    Zheng, Xing-xing
    Ji, Fei
    Zhang, Liu-Lu
    Yang, Ci-Qiu
    Yang, Mei
    Li, Jie-Qing
    Cheng, Min-Yi
    Wang, Kun
    BREAST, 2022, 66 : 126 - 135
  • [50] Effectiveness and safety of neoadjuvant therapy in triple-negative breast cancer in a real-world population
    Garcia, Cristina Galindo
    Acedo, Rocio Diaz
    Criado, Silvia Artacho
    Artacho, Maria Rodriguez de la Borbolla
    FARMACIA HOSPITALARIA, 2024, 48 (06) : T278 - T285
12345